Literature DB >> 11556944

Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.

B J Turner1, J A Fleishman, N Wenger, A S London, M A Burnam, M F Shapiro, E G Bing, M D Stein, D Longshore, S A Bozzette.   

Abstract

OBJECTIVE: To distinguish the effects of drug abuse, mental disorders, and problem drinking on antiretroviral therapy (ART) and highly active ART (HAART) use.
DESIGN: Prospective population-based probability sample of 2,267 (representing 213,308) HIV-infected persons in care in the United States in early 1996. MEASUREMENTS: Self-reported ART from first (January 1997-July 1997) to second (August 1997-January 1998) follow-up interviews. Drug abuse/dependence, severity of abuse, alcohol use, and probable mental disorders assessed in the first follow-up interview. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) estimated from weighted models for 1) receipt of any ART, and 2) receipt of HAART among those on ART.
RESULTS: Of our study population, ART was reported by 90% and HAART by 61%. Over one third had a probable mental disorder and nearly half had abused any drugs, but drug dependence (9%) or severe abuse (10%) was infrequent. Any ART was less likely for persons with dysthymia (AOR, 0.74; CI, 0.58 to 0.95) but only before adjustment for drug abuse. After full adjustment with mental health and drug abuse variables, any ART was less likely for drug dependence (AOR, 0.58; CI, 0.34 to 0.97), severe drug abuse (AOR, 0.52; CI, 0.32 to 0.87), and HIV risk from injection drug use (AOR, 0.55; CI, 0.39 to 0.79). Among drug users on ART, only mental health treatment was associated with HAART (AOR, 1.57; CI, 1.11 to 2.08).
CONCLUSIONS: Drug abuse-related factors were greater barriers to ART use in this national sample than mental disorders but once on ART, these factors were unrelated to type of therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556944      PMCID: PMC1495260          DOI: 10.1046/j.1525-1497.2001.016009625.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  31 in total

Review 1.  Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

Authors:  C C Carpenter; M A Fischl; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Sáag; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  1996-07-10       Impact factor: 56.272

2.  Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.

Authors:  W E Cunningham; L E Markson; R M Andersen; S H Crystal; J A Fleishman; C Golin; A Gifford; H H Liu; T T Nakazono; S Morton; S A Bozzette; M F Shapiro; N S Wenger
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

3.  A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly.

Authors:  C L Turvey; R B Wallace; R Herzog
Journal:  Int Psychogeriatr       Date:  1999-06       Impact factor: 3.878

4.  Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology.

Authors:  J B Williams; J G Rabkin; R H Remien; J M Gorman; A A Ehrhardt
Journal:  Arch Gen Psychiatry       Date:  1991-02

5.  Treatment services in two national studies of community-based drug abuse treatment programs.

Authors:  R M Etheridge; S G Craddock; G H Dunteman; R L Hubbard
Journal:  J Subst Abuse       Date:  1995

6.  Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.

Authors:  B J Turner; C J Newschaffer; D Zhang; L Cosler; W W Hauck
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

7.  Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment.

Authors:  L M Bogart; J A Kelly; S L Catz; J M Sosman
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-15       Impact factor: 3.731

8.  Health care delivery, zidovudine use, and survival of women and men with AIDS.

Authors:  B J Turner; L E Markson; L J McKee; R Houchens; T Fanning
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-12

9.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

10.  Development of screeners for depressive disorders and substance disorder history.

Authors:  K Rost; M A Burnam; G R Smith
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

View more
  63 in total

1.  HIV care and general internal medicine: the next generation.

Authors:  J Cofrancesco; A W Wu
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

2.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

3.  Effects of HIV Medication Complexity and Depression on Adherence to HIV Medication.

Authors:  Virender Kumar; William Encinosa
Journal:  Patient       Date:  2010-03-01       Impact factor: 3.883

Review 4.  The HIV epidemic among individuals with mental illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

5.  Factors associated with HIV viral load in a respondent driven sample in Los Angeles.

Authors:  William D King; Sherry Larkins; Christopher Hucks-Ortiz; Pin-Chieh Wang; Pamina M Gorbach; Rose Veniegas; Steven Shoptaw
Journal:  AIDS Behav       Date:  2007-12-07

6.  HIV-positive smokers considering quitting: differences by race/ethnicity.

Authors:  Elizabeth E Lloyd-Richardson; Cassandra A Stanton; George D Papandonatos; Renée M Betancourt; Michael Stein; Karen Tashima; Kathleen Morrow; Raymond Niaura
Journal:  Am J Health Behav       Date:  2008 Jan-Feb

7.  Association Between Depression and Antiretroviral Therapy Use Among People Living with HIV: A Meta-analysis.

Authors:  Jun Tao; Sten H Vermund; Han-Zhu Qian
Journal:  AIDS Behav       Date:  2018-05

8.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

Review 9.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

10.  HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.

Authors:  Geetanjali Chander; Seth Himelhoch; John A Fleishman; James Hellinger; Paul Gaist; Richard D Moore; Kelly A Gebo
Journal:  AIDS Care       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.